Since 2004, our company has been engaged in scientific research and development of new-generation biotechnological products (including medicines and vaccines). Over the years, we have successfully fulfilled numerous government contracts for research and development, including those from the Ministry of Defense of the Russian Federation and the Federal Medical and Biological Agency of the Russian Federation (FMBA of Russia).

We are permanent members of the All-Russian Society for Invention and Innovation, multiple winners of the Opora of Russia Award in the category "Best Invention" (according to Rospatent), and recipients of Grand Prix and dozens of cups and medals from international exhibitions and competitions in the field of innovation and new technologies.

We design and synthesize PNA, LNA, and gamma-AA peptides for the treatment of cancer. We develop drugs for the prevention and treatment of radiation-induced injuries, such as radioprotectors and radiomitigators.

We also develop antiviral drugs and monoclonal antibodies. We have experience in conducting research on CRISPR/Cas systems, the design of chimeric antigen receptors (CAR-T), and lentiviral-based delivery systems.
We are actively developing the field of anti-age therapy, including the development of in vivo DNA repair systems aimed at slowing down the aging process.

In practical terms, we provide a full range of services for the synthesis and cloning of genetic constructs, peptide synthesis, recombinant synthesis and preparative purification of proteins and plasmid DNA (plDNA), as well as the assessment of the authenticity and purity of samples.

Based on our technologies, we also develop cosmetic products based on recombinant proteins and highly effective specialized food products.

About the Company

Design and genetic engineering of recombinant protein molecules (native and chimeric with specified parameters), DNA constructs (expression vectors, vectors for DNA vaccines, etc.)